Edition:
United States

People: Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

347.50DKK
16 Aug 2019
Change (% chg)

kr.4.60 (+1.34%)
Prev Close
kr.342.90
Open
kr.339.60
Day's High
kr.347.70
Day's Low
kr.338.40
Volume
3,385,624
Avg. Vol
2,459,338
52-wk High
kr.349.70
52-wk Low
kr.265.15

Fruergaard Joergensen, Lars 

Mr. Lars Fruergaard Joergensen has been appointed President and Chief Executive Officer of Novo Nordisk A/S, effective as of January 1, 2017. He has previously served as Executive Vice President and Chief of Staff of Novo Nordisk A/S since November 24, 2014. He was Executive Vice President for Information Technology, Quality & Corporate Development of the Company from January 31, 2013 until November 24, 2014. He joined Novo Nordisk in 1991 as Economist in Health Care, Economy and Planning and has over the years completed overseas postings in the United States and Japan. In 2004, he was appointed Senior Vice President for IT (Information Technology) and Corporate Development. He holds a Master of Science degree in Finance and Business Administration from Aarhus School of Business, Aarhus University (Aarhus Universitet), Denmark, from 1991.

Basic Compensation

Total Annual Compensation, DKK 24,800,000
Restricted Stock Awards, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 24,800,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --